PDF《上海昊海生物科技股份有限公司》

Shanghai Haohai Biological Technology Co.

, Ltd.* 上海昊海生物科技股份有限公司 (a joint stock company incorporated in the People's Republic of China with limited liability) (於中华人民共和国注册成立的股份有限公司) (Stock Code 股份代号: 6826) NOTIFICATION LETTER 通知信函

10 May

2019 Dear Non-registered Holder(s) (Note 1) , Shanghai Haohai Biological Technology Co., Ltd.* (the "Company") Notice of Publication of Notice of Annual General Meeting (the "Current Corporate Communication") The Chinese and English versions of the Company's Current Corporate Communication are available on the Company's website at www.3healthcare.com and The Stock Exchange of Hong Kong Limited's website at www.hkexnews.hk (the "HKEx's website"). You may access the Current Corporate Communication through the Company's website or the HKEx's website. If you want to receive a printed version of the Current Corporate Communication, please complete the request form (the "Request Form") on the reverse side and return it to the Company's H share registrar, Computershare Hong Kong Investor Services Limited by using the mailing label at the bottom of the Request Form (a stamp is not required if posted in Hong Kong). The address of the H share registrar is 17M Floor, Hopewell Centre,

183 Queen's Road East, Wanchai, Hong Kong. The Request Form may also be downloaded from the Company's website or the HKEx's website. Please note that your instruction on the Request Form will apply to all future Corporate Communications (Note 2) to be sent to you until you notify the Company c/o the H share registrar to the contrary or unless you have at any time ceased to hold shares in the Company. Should you have any queries relating to any of the above matters, please call the telephone hotline of the Company's H share registrar at (852)

2862 8688 during business hours from 9:00 a.m. to 6:00 p.m., Monday to Friday, excluding public holidays or send an email to shhaohaibiotech.ecom@computershare.com.hk. By order of the Board of Directors Shanghai Haohai Biological Technology Co., Ltd. Hou Yongtai Chairman Notes: (1) This letter is addressed to Non-registered Holders ("Non-registered Holder" means such person or company whose shares are held in The Central Clearing and Settlement System (CCASS) and who has notified the Company from time to time through Hong Kong Securities Clearing Company Limited to receive Corporate Communications). If you have sold or transferred your shares in the Company, please disregard this letter and the Request Form on the reverse side. (2) Corporate Communications refer to any documents issued or to be issued by the Company including but not limited to (a) the directors' reports, annual accounts together with a copy of the auditors' report and, when applicable, summary financial reports;

(b) interim reports and, where applicable, summary interim reports;

(c) notices of meetings;

(d) listing documents;

(e) circulars;

(f) proxy forms and (g) reply slips. * For identification purposes only 各位非登记持有人( 注1) : 上海昊海生物科技股份有限公司( 「本公司」 ) 股东周年大会之会议通告( 「本次公司通讯」 )之发布通知 本公司的本次公司通讯的中、英文版本已上载於本公司网站www.3healthcare.com 及香港联合交易所有限公司网站www.hkexnews.hk( 「?交所网站」 ) . 阁下可在本公司网站或在?交所网站阅览本次公司通讯. 如 阁下欲收取本次公司通讯之印刷本,请填妥在本函背面的申请表格( 「申请表格」 ) ,并使用申请表格底部随附之邮寄标签 寄回本公司之 H 股股份过户登记处香港中央证券登记有限公司(如在香港投寄则无须贴上邮票) .H 股股份过户登记处地址为 香港湾仔皇后大道东